The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
EBioMedicine
(Dec 2020)
Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test”
Thomas Weiland,
Luka Brcic,
Markus Reinholz,
Lars E. French,
Dietmar Thurnher
Affiliations
Thomas Weiland
Department of Otorhinolaryngology-Head&Neck Surgery, Medical University of Graz, Graz, Austria; Corresponding author.
Luka Brcic
Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
Markus Reinholz
Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany
Lars E. French
Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany
Dietmar Thurnher
Department of Otorhinolaryngology-Head&Neck Surgery, Medical University of Graz, Graz, Austria
Journal volume & issue
Vol. 62
p. 103139
Abstract
Read online
No abstracts available.
WeChat QR code
Close